Drug · DIN 02446057
REPATHA
1 ML SINGLE-USE PREFILLED SYRINGE AND AUTO-INJECTOR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 28, 2015; first marketed September 28, 2015.
- Drug Identification Number (DIN)
- 02446057
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Evolocumab C10AX13
- Class
- Human
- Record last updated
- August 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EVOLOCUMAB | 140 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 10, 2015: NOC 17318New Drug Submission (NDS)
Other DINs named REPATHA
- DIN 02459779 · Cancelled Post Market